Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 7

1.

Microbial targeting of 99mTc-labeled recombinant human beta-defensin-3 in an animal model of infection: a feasibility pilot study.

Liberatore M, Pala A, Scaccianoce S, Anagnostou C, Di Tondo U, Calandri E, D'Elia P, Gross MD, Rubello D.

J Nucl Med. 2009 May;50(5):823-6. doi: 10.2967/jnumed.108.055533. Epub 2009 Apr 16.

2.

99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe.

Zhao M, Li Z, Bugenhagen S.

J Nucl Med. 2008 Aug;49(8):1345-52. doi: 10.2967/jnumed.107.048603. Epub 2008 Jul 16.

3.

The human beta-defensin-3, an antibacterial peptide with multiple biological functions.

Dhople V, Krukemeyer A, Ramamoorthy A.

Biochim Biophys Acta. 2006 Sep;1758(9):1499-512. Epub 2006 Jul 21. Review.

4.

Human defensins.

Schneider JJ, Unholzer A, Schaller M, Schäfer-Korting M, Korting HC.

J Mol Med (Berl). 2005 Aug;83(8):587-95. Epub 2005 Apr 9. Review.

PMID:
15821901
5.

Radiopharmaceuticals: new antimicrobial agents.

Lupetti A, Nibbering PH, Welling MM, Pauwels EK.

Trends Biotechnol. 2003 Feb;21(2):70-3. Review.

PMID:
12573855
6.

Radiopharmaceuticals to image infection and inflammation.

Boerman OC, Rennen H, Oyen WJ, Corstens FH.

Semin Nucl Med. 2001 Oct;31(4):286-95. Review.

PMID:
11710771
7.

99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections.

Welling MM, Lupetti A, Balter HS, Lanzzeri S, Souto B, Rey AM, Savio EO, Paulusma-Annema A, Pauwels EK, Nibbering PH.

J Nucl Med. 2001 May;42(5):788-94.

Supplemental Content

Support Center